Archives of Clinical Gastroenterology

Research Article

 The Effect on Gastric Emptying of Telaprevir-Based Triple Therapy for Chronic Hepatitis C Patients
Aim: We evaluated food intake in telaprevir-based triple therapy (telaprevir, pegylated-interferon, and ribavirin) and its relation to Gastric Emptying (GE).
Methods: 17 patients　received telaprevir combined with pegylated interferon plus ribavirin. The GE study was carried out using the 13C-acetate breath test and GE time was expressed as the peak time of 13CO2 excretion (Tmax). Results: The average food intake was 1,851 ± 91, 1,338 ± 537 and 1,453 ± 537 kcal at 0, 1, and 2 weeks after the start of treatment, respectively, showing a significant decrease compared to that before treatment (p < 0.01 and p <0.05, paired t-test). The averages of Tmax values at 0, 1, and 2 weeks after the start of treatment were 48.4 ± 14.3 min, 56.9 ± 18.4 min and 58.0 ± 19.9 min, respectively. There was a significant difference between baseline and 1 week after the start of treatment (p<0.05, paired t-test). Food intake (kcal) showed a good correlation with the decrease of Tmax values (minutes) (Pearson’s correlation test, r = -0.49, p < 0.05).
Conclusions: Telaprevir-based triple therapy caused reduced food intake and worsened GE. 

 http://www.peertechz.com/Clinical-Gastroenterology/pdf/ACG-1-104.pdf

Comments

Post a Comment

Popular posts from this blog

Case Report: Reynolds Syndrome

International Journal of Dermatology and Clinical Research Case Report Reynolds et al. described in 1971, 6 patients with classical primary biliary cholangitis, who presented concomitantly with varying degrees of scleroderma. Since then this association has been called Reynolds Syndrome.  https://www.peertechz.com/articles/case-report-reynolds-syndrome.pdf  #ReynoldsSyndrome#
Read more

Successful treatment of Budd- Chiari Syndrome with Percutaneous transluminal Balloon Angioplasty

Journal of Cardiovascular Medicine and Cardiology Case Report Introduction: Budd-Chiari syndrome (BCS) is a relatively rare disease in which an obstruction of hepatic venous outfl ow causes intrahepatic venous congestion and portal hypertension.     https://www.peertechz.com/articles/successful-treatment-of-budd-chiari-syndrome-with-percutaneous-transluminal-balloon-angioplasty.pdf
Read more

Ministernotomy Thymectomy in Mysthania Gravis-Future

Journal of Cardiovascular Medicine and Cardiology Research Article A thymectomy is the surgical removal of the thymus gland. The thymus has been demonstrated to play a role in the development of MG. It is removed in an effort to improve the weakness caused by MG, and to remove a thymoma if present.About 10% of MG patients have a tumor of the thymus called a thymoma. https://www.peertechz.com/articles/ministernotomy-thymectomy-in-mysthania-gravis-future.pdf  
Read more